Replies to post #2884 on Cytodyn Inc (CYDY)

[Inoviorulez]

Totally wrong. no way its only peak sales of $1.28 billion. The market for adjunct therapy is $5 billion and the monotherapy is $11 billion.

[tpizzazz24]

I wouldn't wipe my dogs azz with an SA article. Yes, I'm that great a dog owner lol

[dlcullum]

Unfortunately, I still have a couple concerns. First, this valuation relies on commercialization of PRO140 in 2017. With the trial delays, Phase 3 is slated for release at the end of 2017, which means commercialization sometime in 2018. That is not particularly problematic, except that the trial delay may give Ibalizumab time to come up with SC administration. If this occurs, the trial delay may ultimately result in a lower market share for PRO140. Thoughts?